Skip to content

Precigen PGEN Accumulated Depreciation

Accumulated Depreciation at other companies

Merck & Co. logo
Merck & Co.MRK
$22.29B+13.3%
Gilead Sciences logo
Gilead SciencesGILD
BridgeBio Pharma logo
BridgeBio PharmaBBIO
Amgen logo
AmgenAMGN
AbbVie logo
AbbVieABBV

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$1.91B+213%
Enterprise value$2B+234%
P/S72×

Profitability

See full
Gross margin83.6%
Operating margin-2,890.9%
Net margin-3,656%
FCF margin-1,756.5%

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×
Current ratio4.8×+1.3×

Where this comes from

Reported directly by Precigen in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.

The official record: Precigen’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Precigen's accumulated depreciation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Precigen's accumulated depreciation?
Precigen (PGEN) reported accumulated depreciation of $24.6M in Q1 2026.
How has Precigen's accumulated depreciation changed year-over-year?
Precigen's accumulated depreciation increased by 6.1% year-over-year, from $23.18M to $24.6M.
What is the long-term trend for Precigen's accumulated depreciation?
Over 5 years (2020 to 2025), Precigen's accumulated depreciation has grown at a -7.4% compound annual growth rate (CAGR), from $34.95M to $23.82M.
What does accumulated depreciation mean?
Total accumulated depreciation on property, plant, and equipment since acquisition — represents the consumed portion of asset useful lives.